Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neogenomics Inc NEO

Healthcare
NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical... see more

Recent & Breaking News (NDAQ:NEO)

NEO SHAREHOLDER ALERT: Jakubowitz Law Reminds NeoGenomics Shareholders of a Lead Plaintiff Deadline of February 6, 2023

PR Newswire February 3, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO

Newsfile February 2, 2023

NeoGenomics Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 6, 2023 to Discuss Your Rights - NEO

Newsfile February 2, 2023

NEO Investors Have Opportunity to Lead NeoGenomics, Inc. Securities Fraud Lawsuit

Newsfile February 2, 2023

Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NeoGenomics, Inc. (NEO) Investors of Class Action and to Actively Participate

Newsfile February 2, 2023

NEO LAWSUIT ALERT: Levi & Korsinsky Notifies NeoGenomics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire February 2, 2023

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of NeoGenomics, Inc. - NEO

PR Newswire February 1, 2023

NeoGenomics Class Action: Levi & Korsinsky Reminds NeoGenomics, Inc. Investors of The Pending Class Action Lawsuit With a Lead Plaintiff Deadline of February 6, 2023 - NEO

Newsfile February 1, 2023

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NeoGenomics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 6, 2023 - (NASDAQ: NEO)

PR Newswire February 1, 2023

NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NeoGenomics, Inc. (NASDAQ: NEO)

PR Newswire February 1, 2023

NEO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 6, 2023 in the Class Action Filed on Behalf of NeoGenomics, Inc. Shareholders

PR Newswire January 31, 2023

NEO FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NEO

PR Newswire January 30, 2023

NEOGENOMICS, INC. (NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NeoGenomics, Inc. (NEO)

Newsfile January 30, 2023

NEO Investors Have Opportunity to Lead NeoGenomics, Inc. Securities Fraud Lawsuit

PR Newswire January 30, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO

PR Newswire January 30, 2023

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind NeoGenomics Investors of a Lead Plaintiff Deadline of February 6, 2023

PR Newswire January 30, 2023

NEO IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NEO

Newsfile January 29, 2023

NEOGENOMICS SHAREHOLDER NOTICE:Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In NeoGenomics To Contact Him Directly To Discuss Their Options

PR Newswire January 28, 2023

NEOGENOMICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO

PR Newswire January 27, 2023

NEO SHAREHOLDER ALERT: Jakubowitz Law Reminds NeoGenomics Shareholders of a Lead Plaintiff Deadline of February 6, 2023

PR Newswire January 27, 2023